YOLFTbeta
10

High Tech Pharm Co. Ltd

106190 · KQ · Healthcare / Drug Manufacturers - Specialty & Generic

8,650.00KRW-10.00 (-0.12%)

Price History

Full chart

Market Stats

Previous Close8,660.00
Open8,650.00
Day Range8,480.00 – 8,700.00
52-Week Range9,500.00 – 25,000.00
Volume12.50K
Market Cap107.39B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield1.50%
Beta0.03
50-Day Avg10,753.40
200-Day Avg13,910.50

About

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Jeong-Soo Kim
  • Employees0
  • Headquarters12, Cheomdansaneop 6-ro, Chungju-si, South Korea, 27466, Korea
  • Websitehttps://www.htpharm.com

Leadership

  • Mr. Jeong-Soo KimChief Executive Officer · b. 1958

Financials

Income Statement

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue56.90B48.09B54.84B66.05B66.39B63.07B74.46B73.29B102.95B76.77B77.51B70.18B
Growth (%)--15.48%+14.02%+20.45%+0.51%-5.00%+18.07%-1.58%+40.47%-25.43%+0.97%-9.46%
Cost of Revenue46.07B40.77B47.49B60.52B61.68B65.18B73.15B70.21B95.17B63.93B58.03B53.24B
Gross Profit10.83B7.32B7.34B5.53B4.71B-2.12B1.31B3.08B7.78B12.84B19.49B16.94B
Gross Margin19.04%15.22%13.39%8.38%7.10%-3.36%1.77%4.20%7.56%16.73%25.14%24.14%
Operating Expense2.95B1.92B2.17B2.26B2.63B2.41B4.64B3.49B2.85B2.75B3.93B4.09B
Operating Income7.89B5.40B5.18B3.27B2.08B-4.52B-3.32B-412.02M4.93B10.09B15.56B12.86B
Operating Margin13.86%11.22%9.44%4.95%3.14%-7.17%-4.46%-0.56%4.79%13.14%20.07%18.32%
EBITDA--------10.04B15.75B23.04B19.42B
EBITDA Margin--------9.75%20.51%29.73%27.68%
Net Income7.84B6.54B5.28B2.10B2.61B-4.22B-3.15B-1.23B5.87B8.08B13.71B11.48B
Net Income Margin13.77%13.61%9.63%3.18%3.93%-6.69%-4.23%-1.67%5.70%10.52%17.69%16.35%
R&D24.73M80.45M19.30M100.95M-------816.56M
R&D as % of Total Revenue0.04%0.17%0.04%0.15%-------1.16%
Interest Expense00000334.75M327.02M252.07M463.69M896.47M787.26M180.16M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.53%0.44%0.34%0.45%1.17%1.02%0.26%

Balance Sheet

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets106.60B111.43B118.31B119.10B133.00B131.73B128.45B122.94B132.20B135.06B140.09B143.70B
Total Liabilities14.53B14.23B17.13B16.90B29.65B33.14B33.30B29.05B32.26B28.06B20.35B13.03B
Total Equity92.06B97.20B101.18B102.19B103.35B98.58B95.14B93.88B99.94B106.99B119.74B130.67B
Cash20.80B22.95B10.06B3.00B3.96B3.11B1.03B3.18M5.68M3.48B7.76B13.08B
Total Debt-1.30B1.35B-7.24B10.81B10.48B-----
Net Debt------9.40B4.65B8.46B12.96B181.06M-

Cash Flow

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow10.17B12.71B1.45B5.45B5.38B2.48B-7.69B6.93B-3.70B2.91B14.69B17.03B
Investing Cash Flow-9.11B-6.47B-13.54B-11.39B-10.27B-6.32B6.01B-1.29B730.36M-6.76B-1.14B-
Financing Cash Flow1.34B-4.34B-1.06B-1.06B5.86B3.02B-393.50M4.62B-390.12M-529.11M-9.42B-
Capital Expenditure9.38B19.52B23.35B11.27B8.96B2.16B937.17M859.60M655.97M5.09B2.13B1.93B
Free Cash Flow-------8.63B6.07B-4.36B-2.18B12.56B15.10B
Dividends Paid1.77B1.77B1.06B1.06B708.88M354.44M354.44M354.44M354.44M496.21M708.88M1.06B
FCF to OCF------112.19%87.59%117.71%-75.04%85.48%88.69%
Dividend Paid to FCF-------4.11%5.84%-8.13%-22.74%5.64%7.04%

Earnings

Report DateSep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 12, 2016Nov 11, 2016Mar 15, 2017May 15, 2017Aug 14, 2017Nov 14, 2017Feb 6, 2018May 15, 2018Aug 10, 2018Nov 14, 2018Mar 14, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Feb 4, 2020May 11, 2020Aug 14, 2020Nov 11, 2020Feb 3, 2021Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------------------------
EPS Actual241.33368.44251.33366.96240.08127.90225.74323.63190.83-16.84304.95423.01144.81110.52192.5178.49243.99222.19111.41270.46200.1527.2591.16283.87-34.90359.1919.42151.95155.93-31.0995.57183.50134.41-45.5168.070.45-152.32-511.20-6.08-366.0089.00-161.7042.78-40.06-5.24-123.96-110.74126.58108.63427.86-23.66233.02125.91424.29307.31414.25223.34344.53205.42219.42356.53293.97-25.11493.33
Surprise----------------------------------------------------------------
Timing-----------------------Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-After-hoursPre-marketPre-market--Pre-marketPre-marketPre-market-----------------------

Key Statistics & Ratios

Market Cap107.39B
Enterprise Value102.07B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.55
Price / Book0.78
Revenue (TTM)69.41B
Gross Profit (TTM)18.98B
EBITDA17.81B
Profit Margin17.18%
Operating Margin26.92%
Return on Equity9.27%
Return on Assets5.28%
Shares Outstanding10.63M
Shares Float5.82M
Beta0.03
Dividend Yield1.50%
Dividend Rate150.00
Payout Ratio13.41%

Dividends

20251×
150.00Dec 29, 2025
20241×
100.00Dec 27, 2024
20231×
100.00Dec 27, 2023
20221×
46.67Dec 28, 2022
20211×
33.33Dec 29, 2021
20201×
33.33Dec 29, 2020
20191×
33.33Dec 27, 2019
20181×
33.33Dec 27, 2018
20171×
66.67Dec 27, 2017
20161×
100.00Dec 28, 2016
20151×
100.00Dec 29, 2015
20141×
166.67Dec 29, 2014
20131×
166.67Dec 27, 2013
20121×
133.33Dec 27, 2012
20111×
93.33Dec 28, 2011
20101×
46.67Dec 29, 2010

Stock Splits

  • Dec 27, 2023479156:319437